RESEARCH NOTE. T-cell responses against tuberculin and sensitin in children with tuberculosis and non-tuberculosis mycobacterial lymphadenopathy
|
|
- Lester Thornton
- 5 years ago
- Views:
Transcription
1 Research Notes Teng LJ, Hsueh PR, Tsai JC et al. groesl sequence determination, phylogenetic analysis, and species differentiation for viridans group streptococci. J Clin Microbiol 2002; 40: Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994; 22: Drancourt M, Roux V, Fournier PE, Raoult D. rpob gene sequence-based identification of aerobic gram-positive cocci of the genera Streptococcus, Enterococcus, Gemella, Abiotrophia, and Granulicatella. J Clin Microbiol 2004; 42: Täpp J, Thollesson M, Herrmann B. Phylogenetic relationships and genotyping of the genus streptococcus by sequence determination of the RNase P RNA gene, rnpb. Int J Syst Evol Microbiol 2003; 53: RESEARCH NOTE T-cell responses against tuberculin and sensitin in children with tuberculosis and non-tuberculosis mycobacterial lymphadenopathy K. Magdorf 1, S. D. Schuck 2, S. Leitner 2, U. Wahn 1, S. H. E. Kaufmann 2 and M. Jacobsen 2, 1 Department of Paediatric Pneumology and Immunology, Charité, Universitätsmedizin Berlin and 2 Department of Immunology, Max Planck Institute for Infection Biology, Berlin, Germany ABSTRACT Multi-colour flow cytometry was applied to determine T-cell-specific interferon-c, interleukin-2 and tumour necrosis factor-a expression in children with tuberculosis and non-tuberculosis mycobacterial lymphadenopathy (-L). In vitro stimulation of peripheral blood mononuclear cells with purified protein derivative from Mycobacterium tuberculosis (tuberculin) and M. avium (sensitin) Corresponding author and reprint requests: M. Jacobsen, Department of Immunology, Max Planck Institute for Infection Biology, Charitéplatz 1, Berlin, Germany jacobsen@bni-hamburg.de Present address: Department of Immunology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany revealed differential recognition of tuberculin and sensitin in both study groups. Ratios of tuberculinspecific and sensitin-specific T-cell proportions in individual patients discriminated between children with tuberculosis or -L. These findings have the potential to improve the differential diagnosis of mycobacterial infections. Keywords Childhood tuberculosis, flow cytometry, intracellular cytokine staining, non-tuberculosis mycobacterial, sensitin, tuberculin Original Submission: 11 January 2008; Revised Submission: 19 March 2008; Accepted: 23 May 2008 Edited by F. Mescart Clin Microbiol Infect 2008; 14: /j x Lymphadenopathy in children can be caused by M. tuberculosis or non-tuberculosis mycobacteria () [1]. Rates of non-tuberculosis mycobacterial lymphadenopathy (-L) in children have increased during recent years in industrialized countries, whereas tuberculosis rates are decreasing [2,3]. Differential diagnosis of tuberculosis and -L has major implications for the treatment procedure but can only be accomplished by bacterial culture lasting at least 3 weeks. Consequently, presumptive diagnosis that relies on clinical findings, patient anamnesis and tuberculin skin test (TST) guides the treatment choice. Different approaches have been evaluated to improve the differential diagnosis of tuberculosis and -L. On the one hand, the TST induration sizes induced by tuberculin have been analysed [4,5]. These studies identified differences in the mean induration size between -infected and M. tuberculosis-infected individuals. However, high variances between individuals and the marked overlap between the study groups rendered induration sizes insufficient as biomarkers, especially in paediatric cases [4]. On the other hand, concomitant TST analyses of tuberculin and sensitin (dual skin testing) have been performed [4,6]. Dual skin testing and calculation of the ratio of responses against each antigen discriminated between and M. tuberculosis infection in adults [6,7], whereas results from studies in children were less convincing [8]. These ambiguous results may be caused by cross-reactivity against the antigens prevalent in both tuberculin and sensitin preparations.
2 1080 Clinical Microbiology and Infection, Volume 14 Number 11, November 2008 Table 1. Clinical characteristics of children with tuberculosis (A I) and children with non-tuberculosis mycobacterial lymphadenopathy (J R) Case Age Gender TST (mm) QuantiFERON Ò Gold T-SPOT Ò Pathogen (from gastric lavage, bronchoscopy, or extirpated lymph nodes) Clinical features A 5 years F 30 Positive Positive M. tuberculosis Primary pulmonary tuberculosis; culture-confirmed B 9 years M 30 Positive Positive M. tuberculosis Primary pulmonary tuberculosis; culture-confirmed C 4 years M 20 Positive Positive M. tuberculosis Primary pulmonary tuberculosis; culture-confirmed D 8 months F 8 Negative Negative M. tuberculosis Primary pulmonary tuberculosis; culture-confirmed E 10 years F 30 Positive Positive M. tuberculosis Primary pulmonary tuberculosis; culture-confirmed F 14 years M 20 Positive Positive M. tuberculosis Primary pulmonary tuberculosis; culture-confirmed G 4 years F 20 Positive Positive M. tuberculosis Primary pulmonary tuberculosis; culture-confirmed H 5 years F 20 Positive Positive M. tuberculosis Multiresistant primary pulmonary tuberculosis; culture-confirmed I 8 years F 20 Positive Positive M. tuberculosis Primary pulmonary tuberculosis; culture-confirmed J 8 years F 20 Negative Negative M. avium Lymphadenopathy; culture-confirmed K 2 years M 15 Negative Negative M. avium Lymphadenopathy; culture-confirmed L 5 years M 10 Negative Negative M. avium Lymphadenopathy; culture-confirmed M 3 years M 10 Negative Negative M. avium Lymphadenopathy; culture-confirmed N 5 years F 6 ND Negative M. avium Lymphadenopathy; culture-confirmed O 6 years M 10 Negative ND M. avium Lymphadenopathy; culture-confirmed P 2 years F 10 Negative Negative M. intracellulare Lymphadenopathy; culture-confirmed Q 2 years F 3 Negative Negative M. avium Lymphadenopathy; culture-confirmed R 3 years F 10 Negative Negative M. intracellulare Lymphadenopathy; culture-confirmed TST, tuberculin skin test; F, female; M, male; ND, not defined. RT23, 2 TU (Statens Serum Institute, Copenhagen, Denmark). Here we used flow cytometry, a highly sensitive and specific method, to determine specific T-cell responses against purified protein derivative from M. tuberculosis (tuberculin) and purified protein derivative from M. avium (sensitin) in children with tuberculosis or -L. Intracellular analyses of cytokines, namely interferon-c (IFN-c), tumour necrosis factor-a (TNF-a), and interleukin-2 (IL-2), were used as readouts after short-term in vitro restimulation. Peripheral blood (3 ml) was obtained from ten children with culture-confirmed tuberculosis and nine children with culture-confirmed -L recruited at the Department of Paediatric Pneumology and Immunology, Charité, in Berlin, Germany. The patients characteristics are summarized in Table 1. This study was approved by the local ethics committee (EA ). Peripheral blood mononuclear cells (PBMCs) were isolated by density centrifugation, (Biocoll; Invitrogen, Carlsbad, CA, USA) following the manufacturer s instructions. PBMCs ( cells well) were then stimulated with tuberculin, sensitin (each 10 lg ml) (Statens Serum Institute, Copenhagen, Denmark), or Staphylococcus enterotoxin B (1 lg ml) (Sigma-Aldrich, St. Louis, MI, USA), or were unstimulated for 20 h in 200 ll of RPMI (Gibco) containing 5% human serum (Sigma) and 1% L-glutamine (Sigma). During the final 15 h, brefeldin A was added to avoid release of cytokines from the Golgi apparatus. Cells were then fixed and permeabilized using BD Biosciences (New Jersey, USA) cytofix cytoperm, following the manufacturer s instructions, before monoclonal antibody (mab) mixtures were added. These mab mixtures contained anti-ifn-c mab (APC-labelled), anti-il-2 mab (fluorescein isothiocyanate-labelled), and anti-tnf-a mab (Alexa 700-labelled) (all BD Biosciences), combined with anti-cd4 mab (APC-Cy7-labelled), anti-cd3 mab (Pacific Blue-labelled), and anti-cd45ro mab (PE-Cy7- labelled). An LSRII flow cytometer (BD Biosciences) was used for measurement, and FCS express software (De Novo, Los Angeles, CA, USA) was used for data analyses (see Fig. S1 for gating procedures). The Mann Whitney U-test was used to determine significant differences in cytokine-expressing T-cell proportions between study groups, and Student s t-test was applied to compare ratios of stimulation values. These tests were selected on the basis of Kolmogorov Smirnov normality testing with Lilliefors correction. CD4 + T-cells were the predominant cytokineproducing T-cell population after antigen-specific in vitro stimulation (data not shown). The proportions of IFN-c-expressing, IL-2-expressing and TNF-a-expressing T-cells after restimulation with tuberculin in PBMCs from children with tuberculosis were only slightly higher than those in PBMCs from children with -L (Fig. 1a). For sensitin, slightly higher IFN-c-expressing, IL-2- expressing and TNF-a-expressing T-cell propor-
3 Research Notes 1081 (a) IFNγ IL-2 TNFα (b) IFNγ IL-2 TNFα (c) IFNγ IL-2 TNFα (d) IFNγ IL-2 TNFα (e) IFNγ IL-2 Ratios of tuberculin / sensitin specific CD4 + T cells TNFα Fig. 1. Proportions of interferon-c (IFN-c)-expressing, interleukin-2 (IL-2)-expressing and tumour necrosis factor-a (TNFa)- expressing memory T-cells from children with tuberculosis () and non-tuberculosis mycobacterial lymphadenopathy (-L). Multiple scattergraphs indicate IFN-c-expressing (left panel, squares), IL-2-expressing (middle panel, circles), and TNF-a-expressing (right panel, triangle) (separated by dotted lines) T-cell proportions specific for (a) tuberculin and (b) sensitin in peripheral blood mononuclear cells (PBMCs) from children with tuberculosis (dark grey symbols) and those with -L (bright grey symbols). (c, d) Comparisons of individual tuberculin-specific and sensitin-specific T-cell proportions of children with tuberculosis (c) and -L (d) are shown. Symbols from same patients are connected by straight lines. Presentations are as described for (a) and (b). (e) Ratios (tuberculin sensitin) of cytokine-secreting memory T-cell proportions in PBMCs from individual patients are shown. Each symbol represents a ratio from an individual donor. Normality testing was performed using Kolmogorov Smirnov testing with Lilliefors correction. Accordingly, two-sided p values for the Mann Whitney U-test are indicated as p <5) and p <1) in (a d), and Student s t-test values as p <01) in (e). tions were detected in PBMCs of children with -L than in those of children with tuberculosis (p <5; for all cytokines) (Fig. 1b). No differences were detected in the T-cell responses to the superantigen Staphylococcus enterotoxin B between the study groups (data not shown). Owing to the strong variations in cytokine responses of individual donors, the percentages induced by tuberculin and sensitin overlapped markedly between the study groups (Fig. 1a,b). Therefore, comparison of IFN-c-secreting, IL-2- secreting and TNF-a-secreting T-cell proportions
4 1082 Clinical Microbiology and Infection, Volume 14 Number 11, November 2008 specific for tuberculin or sensitin was insufficient to discriminate between children with tuberculosis and those with -L. Next, the CD4 + T-cell responses to tuberculin and sensitin were determined for each individual donor. Significantly higher proportions of tuberculin-specific T-cells were detected in children with tuberculosis (Fig. 1c) and significantly higher proportions of sensitin-specific T-cells in children with -L (Fig. 1d) (p <5; for all cytokines). As the relative proportions of tuberculin-specific and sensitin-specific T-cells correlated strongly in individual patients (p <1 for all three cytokines in both study groups, data not shown), crossreactivity against the antigens is likely, as has been described by others [5]. Consequently, the ratios of cytokine-expressing T-cell proportions induced by tuberculin and sensitin were determined in individual patients from both study groups. The individual cytokine ratios revealed highly significant differences between the study groups for IFN-c (p <01), IL-2 (p <01), and TNF-a (p <01) (Fig. 1e). Notably, ratios of cytokine-expressing T-cell proportions revealed non-overlapping results for all cytokines between children with tuberculosis and those with -L (Fig. 1e). These results were in accordance with studies comparing dual skin testing with tuberculin and sensitin in adults, and demonstrated for the first time that the analysis of T-cell responses against both mycobacterial protein preparations in parallel can contribute to improved differential diagnosis in children [7]. In particular, the high specificity of flow cytometry-based analyses and the enrolment of strictly stratified study groups (Table 1) may account for the contradictory results obtained in previous studies concerning dual skin testing in children [8]. The present study suggests that both sensitin and tuberculin preparations contain exclusive immunogenic proteins. For M. tuberculosis, specific immunodominant proteins have been identified and are already being used in diagnostic tests [9,10]. These IFN-c release assays have shown improved specificity and sensitivity as compared to the TST, but are probably less reliable if used for the diagnosis of immunocompromised patients [11]. Immunity based on serological analyses against components specifically expressed by M. avium has been analysed in patients with tuberculosis as well as in those with -L [12,13], with promising results from a very recent study in adults [13]. Our assay provides the possibility of detecting T-cell immunity specific for M. avium infection. This is a major difference from the IFN-c release assays, which detect M. tuberculosis infection. Therefore, we consider our finding to be an initial step to characterize the influence of co-infection with on tuberculosis and other infectious diseases (e.g. human immunodeficiency virus (HIV)). Especially in regions with high incidences of infections, these co-infections are relevant [14]. Furthermore, in immunocompromised donors (e.g. HIV-infected), false-negative results of the TST and of IFN-c release assays are prevalent, and hence the number of truly M. tuberculosis-infected individuals among these patients is underestimated [11]. Ongoing studies will determine the efficacy of our assay in detecting mycobacterial infections in this group of patients. In conclusion, the combined analyses of cytokine-expressing T-cell proportions specific for tuberculin or sensitin in individual patients rather then the response to one of these antigens discriminated between children with tuberculosis and those with -L. All three cytokines, IFN-c, TNF-a and IL-2, were equally suited for discrimination. We consider our findings an initial step to: (i) identify sensitin-specific components; (ii) analyse the impact of co-infections on other infectious diseases (e.g. in patients with HIV infection); and (iii) develop a fast and reliable method for discrimination between children with tuberculosis and those with -L. ACKNOWLEDGEMENTS We thank M. L. Grossman for carefully reading the manuscript. TRANSPARENCY DECLARATION Part of this work received financial support from the Bill and Melinda Gates Foundation (Grand Challenges 6 to S. H. E. Kaufmann and M. Jacobsen). The authors have no conflicting financial interests. SUPPORTING INFORMATION Additional Supporting Information may be found in the online version of this article:
5 Research Notes 1083 Fig. S1. Gating procedures of flow cytometry analyses to determine tuberculin-specific and sensitin-specific T-cell proportions. Please note: Wiley-Blackwell are not responsible for the content or functionality of any supporting materials supplied by the authors. Any queries (other than missing material) should be directed to the corresponding author for the article. REFERENCES 1. Marras TK, Daley CL. Epidemiology of human pulmonary infection with nontuberculous mycobacteria. Clin Chest Med 2002; 23: Haverkamp MH, Arend SM, Lindeboom JA, Hartwig NG, van Dissel JT. Nontuberculous mycobacterial infection in children: a 2-year prospective surveillance study in the Netherlands. Clin Infect Dis 2004; 39: Falzon D, Ait-Belghiti F. What is tuberculosis surveillance in the European union telling us? Clin Infect Dis 2007; 44: Haimi-Cohen Y, Zeharia A, Mimouni M, Soukhman M, Amir J. Skin indurations in response to tuberculin testing in patients with nontuberculous mycobacterial lymphadenitis. Clin Infect Dis 2001; 33: von Reyn CF, Horsburgh CR, Olivier KN et al. Skin test reactions to Mycobacterium tuberculosis purified protein derivative and Mycobacterium avium sensitin among health care workers and medical students in the United States. Int J Tuberc Lung Dis 2001; 5: von Reyn CF, Green PA, McCormick D et al. Dual skin testing with Mycobacterium avium sensitin and purified protein derivative: an open study of patients with M. avium complex infection or tuberculosis. Clin Infect Dis 1994; 19: Hersh AL, Tosteson AN, von Reyn CF. Dual skin testing for latent tuberculosis infection: a decision analysis. Am J Prev Med 2003; 24: Larsson LO, Bentzon MW, Lind A et al. Sensitivity to sensitins and tuberculin in swedish children. Part 5: a study of school children in an inland rural area. Tuber Lung Dis 1993; 74: Detjen AK, Keil T, Roll S et al. Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis. Clin Infect Dis 2007; 45: Lein AD, von Reyn CF, Ravn P, Horsburgh CR Jr, Alexander LN, Andersen P. Cellular immune responses to esat- 6 discriminate between patients with pulmonary disease due to mycobacterium avium complex and those with pulmonary disease due to Mycobacterium tuberculosis. Clin Diagn Lab Immunol 1999; 6: Hornum M, Mortensen KL, Kamper AL, Andersen AB. Limitations of the QùantiFERON- Gold test in detecting Mycobacterium tuberculosis infection in immunocompromised patients. Eur J Intern Med 2008; 19: Rolinck-Werninghaus C, Magdorf K, Stark K et al. The potential of recombinant antigens esat-6, mpt63 and mig for specific discrimination of Mycobacterium tuberculosis and M. avium infection. Eur J Pediatr 2003; 162: Kitada S, Kobayashi K, Ichiyama S et al. Serodiagnosis of Mycobacterium avium complex pulmonary disease using an enzyme immunoassay kit. Am J Respir Crit Care Med 2007; 177: MacDonell KB, Glassroth J. Mycobacterium avium complex and other nontuberculous mycobacteria in patients with HIV infection. Semin Respir Infect 1989; 4: RESEARCH NOTE Distribution of genes encoding iron uptake systems among enteroaggregative Escherichia coli strains isolated from adults with irritable bowel syndrome B. M. Sobieszczańska Department of Microbiology, University of Medicine, Wrocław, Poland ABSTRACT The distribution of genes encoding different iron acquisition systems in enteroaggregative Escherichia coli (EAEC) from adults with irritable bowel syndrome and from healthy controls was examined using a PCR assay. As many as 95.5% of EAEC carried the chua gene coding for a haem receptor, and the majority of these strains also had yersiniobactin-encoding genes. Apart from yersiniobactin, enterobactin was the siderophore most frequently associated with EAEC among those strains examined. Genes encoding aerobactin and salmochelin siderophores were less frequent in the group of EAEC. Keywords Enteroaggregative Escherichia coli, haem receptor, iron uptake systems, irritable bowel syndrome, yersiniobactin Original Submission: 25 March 2008; Revised Submission: 15 April 2008; Accepted: 28 May 2008 Edited by P. Gerner-Smidt Clin Microbiol Infect 2008; 14: /j x Corresponding author and reprint requests: B. M. Sobieszczańska, Department of Microbiology, University of Medicine, 4 Chałubińskiego Street, Wrocław, Poland mapasobie@provider.pl
Identifying TB co-infection : new approaches?
Identifying TB co-infection : new approaches? Charoen Chuchottaworn MD. Senior Medical Advisor, Central Chest Institute of Thailand, Department of Medical Services, MoPH Primary tuberculosis Natural history
More informationTB Intensive Houston, Texas October 15-17, 2013
TB Intensive Houston, Texas October 15-17, 2013 Interferon Gamma Release Assays (IGRA s) Lisa Armitige, MD, PhD October 16, 2013 Lisa Armitige, MD, PhD has the following disclosures to make: No conflict
More informationTB Intensive San Antonio, Texas November 11 14, 2014
TB Intensive San Antonio, Texas November 11 14, 2014 Interferon Gamma Release Assays Lisa Armitige, MD, PhD November 12, 2014 Lisa Armitige, MD, PhD has the following disclosures to make: No conflict of
More informationSupplementary webappendix
Supplementary webappendix This webappendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Portevin D, Moukambi F, Clowes P, et
More informationEvaluation and Treatment of TB Contacts Tyler, Texas April 11, 2014
Evaluation and Treatment of TB Contacts Tyler, Texas April 11, 2014 Interferon Gamma Release Assays: Understanding the Test David Griffith, BA, MD April 11, 2014 David Griffith, BA, MD has the following
More informationReceived 21 August 2007/Returned for modification 14 September 2007/Accepted 11 November 2007
CLINICAL AND VACCINE IMMUNOLOGY, Feb. 2008, p. 327 337 Vol. 15, No. 2 1556-6811/08/$08.00 0 doi:10.1128/cvi.00342-07 Copyright 2008, American Society for Microbiology. All Rights Reserved. Use of Whole-Blood
More informationTB Nurse Case Management San Antonio, Texas July 18 20, 2012
TB Nurse Case Management San Antonio, Texas July 18 20, 2012 IGRA s and Their Use in TB Nurse NCM Lisa Armitige, MD, PhD July 18, 2012 Lisa Armitige, MD, PhD has the following disclosures to make: No conflict
More informationVariation in T-SPOT.TB spot interpretation between independent observers of different laboratories
8 Variation in T-SPOT.TB spot interpretation between independent observers of different laboratories Willeke P.J. Franken 1, Steven Thijsen 2, Ron Wolterbeek 3, John J.M. Bouwman 2, Hanane el Bannoudi
More informationMycobacterial Infections: What the Primary Provider Should Know about Tuberculosis
Mycobacterial Infections: What the Primary Provider Should Know about Tuberculosis Henry F. Chambers, M.D Professor of Medicine, UCSF Topics for Discussion Epidemiology Diagnosis of active TB Screening
More informationstaining and flow cytometry
Detection of influenza virus-specific T cell responses by intracellular by cytokine intracellular staining cytokine staining and flow cytometry Detection of influenza virus-specific T cell responses and
More informationTB Prevention Who and How to Screen
TB Prevention Who and How to Screen 4.8.07. IUATLD 1st Asia Pacific Region Conference 2007 Dr Cynthia Chee Dept of Respiratory Medicine / TB Control Unit Tan Tock Seng Hospital, Singapore Cycle of Infection
More informationReview. Interferon- assays in the immunodiagnosis of tuberculosis: a systematic review. Interferon- assays for tuberculosis diagnosis
Interferon- assays for tuberculosis diagnosis Review Interferon- assays in the immunodiagnosis of tuberculosis: a systematic review Madhukar Pai, Lee W Riley, and John M Colford Jr A major challenge in
More informationTechnical Bulletin No. 172
CPAL Central Pennsylvania Alliance Laboratory QuantiFERON -TB Gold Plus Assay Contact: J Matthew Groeller, MPA(HCM), MT(ASCP), 717-851-4516 Operations Manager, Clinical Pathology, CPAL Jennifer Thebo,
More informationResearch Methods for TB Diagnostics. Kathy DeRiemer, PhD, MPH University of California, Davis Shanghai, China: May 8, 2012
Research Methods for TB Diagnostics Kathy DeRiemer, PhD, MPH University of California, Davis Shanghai, China: May 8, 2012 Overview Why do we need good TB diagnostics? What works? What doesn t work? How
More informationESCMID Online Lecture Library. by author
Tuberculosis prevention in immunodepressed patients M. Carmen Fariñas Álvarez Infectious Diseases.H.U.Marqués de Valdecilla University of Cantabria, Spain DISCLOSURES I have no potential conflicts with
More informationComparison of Tuberculin Skin Test and New Specific Blood Test in Tuberculosis Contacts
Comparison of Tuberculin Skin Test and New Specific Blood Test in Tuberculosis Contacts Inger Brock, Karin Weldingh, Troels Lillebaek, Frank Follmann, and Peter Andersen Department of Infectious Disease
More informationMædica - a Journal of Clinical Medicine
Mædica - a Journal of Clinical Medicine ORIGINAL PAPERS Prospective Comparison of Two Brands of Tuberculin Skin Tests and Quantiferon-TB Gold in-tube Assay Performances for Tuberculosis Infection in Hospitalized
More informationLet s Talk TB A Series on Tuberculosis, A Disease That Affects Over 2 Million Indians Every Year
A Series on Tuberculosis, A Disease That Affects Over 2 Million Indians Every Year Madhukar Pai, MD, PhD Author and Series Editor Camilla Rodrigues, MD co-author Abstract Most individuals who get exposed
More informationTuberculosis (TB) is an important global health problem. A
Monitoring of Peptide-Specific and Gamma Interferon-Productive T Cells in Patients with Active and Convalescent Tuberculosis Using an Enzyme-Linked Immunosorbent Spot Assay Fang-Fang Yang, a Zhi-Quan Tu,
More informationRecruitment of Mycobacterium tuberculosis specific CD4 + T cells to the site of infection for diagnosis of active tuberculosis
Original Article doi: 10.1111/j.1365-2796.2008.02012.x Recruitment of Mycobacterium tuberculosis specific CD4 + T cells to the site of infection for diagnosis of active tuberculosis J. Nemeth 1,2, H.-M.
More informationMAIT cell function is modulated by PD-1 signaling in patients with active
MAIT cell function is modulated by PD-1 signaling in patients with active tuberculosis Jing Jiang, M.D., Xinjing Wang, M.D., Hongjuan An, M.Sc., Bingfen Yang, Ph.D., Zhihong Cao, M.Sc., Yanhua Liu, Ph.D.,
More informationEffect of prolonged incubation time on the results of the QuantiFERON TB Gold In-Tube assay for the diagnosis of latent tuberculosis infection
CVI Accepts, published online ahead of print on 3 July 2013 Clin. Vaccine Immunol. doi:10.1128/cvi.00290-13 Copyright 2013, American Society for Microbiology. All Rights Reserved. 1 2 3 Effect of prolonged
More informationIn our paper, we suggest that tuberculosis and sarcoidosis are two ends of the same spectrum. Given the pathophysiological and clinical link between
In our paper, we suggest that tuberculosis and sarcoidosis are two ends of the same spectrum. Given the pathophysiological and clinical link between the two, we also propose a classification system for
More informationEvaluation of an In Vitro Assay for Gamma Interferon Production in Response to Mycobacterium tuberculosis Infections
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, Nov. 2004, p. 1089 1093 Vol. 11, No. 6 1071-412X/04/$08.00 0 DOI: 10.1128/CDLI.11.6.1089 1093.2004 Copyright 2004, American Society for Microbiology. All
More informationHuman Immunodeficiency Virus Type-1 Myeloid Derived Suppressor Cells Inhibit Cytomegalovirus Inflammation through Interleukin-27 and B7-H4
Human Immunodeficiency Virus Type-1 Myeloid Derived Suppressor Cells Inhibit Cytomegalovirus Inflammation through Interleukin-27 and B7-H4 Ankita Garg, Rodney Trout and Stephen A. Spector,,* Department
More informationDiagnostic Value of Elisa Serological Tests in Childhood Tuberculosis
Diagnostic Value of Elisa Serological Tests in Childhood Tuberculosis by R. Dayal, a G. Sirohi, a M. K. Singh, a P. P. Mathur, a B. M. Agarwal, a V. M. Katoch, b B. Joshi, b P. Singh, b and H. B. Singh
More informationCommunicable Disease Control Manual Chapter 4: Tuberculosis
Provincial TB Services 655 West 12th Avenue Vancouver, BC V5Z 4R4 www.bccdc.ca Communicable Disease Control Manual Definitions Page 1 2.0 DEFINITIONS Many of the definitions that follow are taken from
More informationCHAPTER 3: DEFINITION OF TERMS
CHAPTER 3: DEFINITION OF TERMS NOTE: TB bacteria is used in place of Mycobacterium tuberculosis and Mycobacterium tuberculosis complex in most of the definitions presented here. 3.1 Acid-fast bacteria
More informationTuberculosis Tools: A Clinical Update
Tuberculosis Tools: A Clinical Update CAPA Conference 2014 JoAnn Deasy, PA-C. MPH, DFAAPA jadeasy@sbcglobal.net Adjunct Faculty Touro PA Program Learning Objectives Outline the pathogenesis of active pulmonary
More informationOptimizing Intracellular Flow Cytometry
Optimizing Intracellular Flow Cytometry Detection of Cytokines, Transcription Factors, and Phosphoprotein by Flow Cytometry Presented by Erika O Donnell, PhD, BD Biosciences 23-14876-00 Outline Basic principles
More informationOptimizing Intracellular Flow Cytometry:
Optimizing Intracellular Flow Cytometry: Simultaneous Detection of Cytokines and Transcription Factors An encore presentation by Jurg Rohrer, PhD, BD Biosciences 10.26.10 Outline Introduction Cytokines
More informationWhat the Primary Physician Should Know about Tuberculosis. Topics for Discussion. Life Cycle of M. tuberculosis
What the Primary Physician Should Know about Tuberculosis Henry F. Chambers, M.D Professor of Medicine, UCSF Topics for Discussion Microbiology Epidemiology Common disease presentations Diagnosis of active
More informationUvA-DARE (Digital Academic Repository)
UvA-DARE (Digital Academic Repository) Cervicofacial lymphadenitis in children caused by Mycobacterium haemophilum Lindeboom, J.A.H.; Prins, J.M.; Bruijnesteijn van Coppenraet, E.S.; Lindeboom, R.; Kuiper,
More informationInterferon gamma release assays and the NICE 2011 guidelines on the diagnosis of latent tuberculosis
CLINICAL AUDIT Clinical Medicine 2013, Vol 13, No 4: 362 6 Interferon gamma release assays and the NICE 2011 guidelines on the diagnosis of latent tuberculosis Helen R Mujakperuo, Richard D Thompson and
More informationLATENT TUBERCULOSIS. Robert F. Tyree, MD
LATENT TUBERCULOSIS Robert F. Tyree, MD 1 YK TB OFFICERS Ron Bowerman Elizabeth Roll Mien Chyi (Pediatrics) Cindi Mondesir (Pediatrics) The new guys: Philip Johnson Robert Tyree 2009 CDC TB CASE DEFINITION
More informationInterferon Gamma Release Assay Testing for Latent Tuberculosis Infection: Physician Guidelines
Interferon Gamma Release Assay Testing for Latent Tuberculosis Infection: Physician Guidelines Historically, Latent Tuberculosis Infection (LTBI) diagnosis was based on risk assessment, chest x-ray (CXR)
More informationTB Intensive Tyler, Texas December 2-4, 2008
TB Intensive Tyler, Texas December 2-4, 2008 Interferon Gamma Releasing Assays: Diagnosing TB in the 21 st Century Peter Barnes, MD December 2, 2008 TOPICS Use of interferon-gamma release assays (IGRAs)
More informationPeggy Leslie-Smith, RN
Peggy Leslie-Smith, RN EMPLOYEE HEALTH DIRECTOR - AVERA TRAINING CONTENT 1. South Dakota Regulations 2. Iowa Regulations 3. Minnesota Regulations 4. Interferon Gamma Release Assay (IGRA)Testing 1 SOUTH
More informationSupplementary Figure 1. Example of gating strategy
Supplementary Figure 1. Example of gating strategy Legend Supplementary Figure 1: First, gating is performed to include only single cells (singlets) (A) and CD3+ cells (B). After gating on the lymphocyte
More informationChallenges of Integrating Mucosal Immune Assays into HIV Vaccine Trials KAVI
Challenges of Integrating Mucosal Immune Assays into HIV Vaccine Trials Omu Anzala, MBChB, PhD KAVI University of Nairobi Outline Why mucosal immunology Experience from Kenya Challenges The way forward
More informationStandard Diagnostic Procedure for Tuberculosis: A Review
ISSN: 2249 8656 www.stmjournals.com Standard Diagnostic Procedure for Tuberculosis: A Review Suresh Jaiswal*, Jay Prakash Sah, Bhoopendra Sharma Department of Medical Lab Science, School of Health and
More informationNguyen Van Hung (NTP, Viet Nam)
Technical Consultation Meeting on the Programmatic Management of Latent Tuberculosis Infection 31 August-1 September 2017, Seoul, Republic Korea Adopting new LTBI diagnostics at country level: perspective
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Adaptive immune response biologic response modifiers and, 735 737 S-Adenosylmethionine (SAMe) for hepatitis, 825 826 Albinterferon for hepatitis,
More informationDetecting latent tuberculosis using interferon gamma release assays (IGRA)
Detecting latent tuberculosis using interferon gamma release assays (IGRA) American Society for Microbiology June 2017 Edward Desmond, Ph.D., D (ABMM) San Lorenzo, CA Edward Desmond has no financial connections
More informationLatent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016
Latent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016 Randy Culpepper, MD, MPH Deputy Heath Officer/Medical Director Frederick County Health Department March 16, 2016 2 No
More information2017 Vol. 23 No. 2 PP ISSN (Print)
43 FLORA AND FAUNA ISSN 2456-9364 (Online) 2017 Vol. 23 No. 2 PP 432-438 ISSN 0971-6920 (Print) LONGITUDINAL STUDY OF CD4 AND CD8 T CELLS PRODUCING CYTOKINE DURING DOTS THERAPY IN TB PATIENTS AND HEALTHY
More informationChallenges in Development and Validation of an Intracellular Cytokine Staining assay
Challenges in Development and Validation of an Intracellular Cytokine Staining assay Jenny Hendriks, Crucell Hatching @ EBF, Brussels, June 202 www.crucell.com Vaccines vs Protein therapeutics Protein
More informationEvaluation of Mycobacterium tuberculosis specific T cell response to ESAT-6 and PPD antigen with ELISPOT assay
In the name of God Evaluation of Mycobacterium tuberculosis specific T cell response to ESAT-6 and PPD antigen with ELISPOT assay presented by: M. Taheri Symptoms of TB Cough for more than two week Bloody
More informationTesting for TB. Bart Van Berckelaer Territory Manager Benelux. Subtitle
Testing for TB Bart Van Berckelaer Territory Manager Benelux Subtitle Agenda TB infection pathway TB immunisation Testing options Pre lab considerations of the whole blood ELISA test The T-SPOT.TB test
More informationWhat the Primary Physician Should Know about Tuberculosis. Topics for Discussion. Global Impact of TB
What the Primary Physician Should Know about Tuberculosis Henry F. Chambers, M.D Professor of Medicine, UCSF Topics for Discussion Epidemiology Common disease presentations Diagnosis of active TB Screening
More informationT-CELL RESPONSES ASSESSED USING IGRA AND TST ARE NOT CORRELATED WITH AFB GRADE AND CHEST RADIOGRAPH IN PULMONARY TUBERCULOSIS PATIENTS
T-CELL RESPONSES ASSESSED USING IGRA AND TST ARE NOT CORRELATED WITH AFB GRADE AND CHEST RADIOGRAPH IN PULMONARY TUBERCULOSIS PATIENTS Kiatichai Faksri 1, 4, Wipa Reechaipichitkul 2, 4, Wilailuk Pimrin
More informationTable 9. Policy for Tuberculosis Surveillance and Screening
Policy for Tuberculosis Surveillance and Screening Purpose: to identify active cases of tuberculosis or latent TB among residents and staff of the nursing home in order to prevent transmission in this
More informationClinical Utility of the QuantiFERON TB-2G Test for Elderly Patients With Active Tuberculosis*
CHEST Clinical Utility of the QuantiFERON -2G Test for Elderly Patients With Active Tuberculosis* Yoshihiro Kobashi, MD, PhD; Keiji Mouri, MD; Shinich Yagi, MD; Yasushi Obase, MD, PhD; Naoyuki Miyashita,
More informationof clinical laboratory diagnosis in Extra-pulmonary Tuberculosis
New approaches and the importance of clinical laboratory diagnosis in Extra-pulmonary Tuberculosis Bahrmand.AR, Hadizadeh Tasbiti.AR, Saifi.M, Yari.SH, Karimi.A, Fateh.A, Tuberculosis Dept. Pasteur Institute
More informationUse of Interferon-γ Release Assays (IGRAs) in TB control in low and middle-income settings - EXPERT GROUP MEETING -
Use of Interferon-γ Release Assays (IGRAs) in TB control in low and middle-income settings - EXPERT GROUP MEETING - Date and time: 20-21 July 2010, 09:00 18:00 Venue: Salle B, WHO-HQ, Geneva, Switzerland
More informationIdentification of T-Cell Antigens Specific for Latent Mycobacterium Tuberculosis Infection
Identification of T-Cell Antigens Specific for Latent Mycobacterium Tuberculosis Infection Sebastian D. Schuck 1, Henrik Mueller 1, Frank Kunitz 2, Albert Neher 3, Harald Hoffmann 3, Kees L. C. M. Franken
More informationJournal of Infectious Diseases Advance Access published August 2, 2013
Journal of Infectious Diseases Advance Access published August 2, 2013 1 Reversion and Conversion of Interferon-gamma Release Assay Results in HIV-1 Infected Individuals Maximilian C. Aichelburg 1,*, Thomas
More informationTB Intensive San Antonio, Texas
TB Intensive San Antonio, Texas August 2-5, 2011 Pediatric TB Jeffrey Starke, MD August 5, 2011 Jeffrey Starke, MD has the following disclosures to make: Is on a data safety monitoring board for Hoffman
More informationDiagnosis Latent Tuberculosis. Disclosures. Case
Diagnosis Latent Tuberculosis Neha Shah MD MPH Field Medical Officer Tuberculosis Control Branch California Department of Public Health Centers for Disease Control and Prevention September 2016 1 Disclosures
More informationTherapy for Latent Tuberculosis Infection
Screening and Treatment of LTBI in TB Control in the US Margarita Elsa Villarino MD MPH Division of TB Elimination, CDC April 14, 2004 TB Prevention and Control in the United States The fundamental strategies
More informationBarbara J Seaworth MD Medical Director, Heartland National TB Center Professor, Internal Medicine and Infectious Disease UT Health Northeast
Practical Aspects for Using the Interferon Gamma Release Assay (IGRA) Test Live Webinar July 14, 2017 Barbara J Seaworth MD Medical Director, Heartland National TB Center Professor, Internal Medicine and
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
TB Partial Update Appendix 1 - Scope NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Tuberculosis: interferon gamma tests for the diagnosis of latent tuberculosis (partial
More informationTitle: Role of Interferon-gamma Release Assays in the Diagnosis of Pulmonary Tuberculosis in Patients with Advanced HIV infection
Author's response to reviews Title: Role of Interferon-gamma Release Assays in the Diagnosis of Pulmonary Tuberculosis in Patients with Advanced HIV infection Authors: Adithya Cattamanchi (acattamanchi@medsfgh.ucsf.edu)
More informationPerspective in novel TB vaccine development Mohamed Ridha BARBOUCHE M.D., Ph.D. Department of Immunology Institut Pasteur de Tunis
Perspective in novel TB vaccine development Mohamed Ridha BARBOUCHE M.D., Ph.D. Department of Immunology Institut Pasteur de Tunis Existing TB Vaccine is not effective for global TB epidemic control BCG
More informationORIGINAL ARTICLE. Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients
ERJ Express. Published on July 25, 2007 as doi: 10.1183/09031936.00040007 ORIGINAL ARTICLE Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients Yoshihiro Kobashi, Keiji Mouri, Yasushi
More informationA Clinician s Perspective: Improving Rheumatology Patient Care Using the T-SPOT.TB Test
A Clinician s Perspective: Improving Rheumatology Patient Care Using the T-SPOT.TB Test Solomon Forouzesh, MD, FACD, FACR Medical Director Arthritis Care & Treatment Center Clinical Associate Professor
More informationUnderstanding and Managing Latent TB Infection Arnold, Missouri October 5, 2010
Understanding and Managing Latent TB Infection Arnold, Missouri October 5, 2010 What is Latent TB Infection (LTBI)? Traci Hadley, RN October 5, 2010 LTBI or TB Disease? Presented by : Traci Hadley, RN
More informationTargeted Testing and the Diagnosis of. Latent Tuberculosis. Infection and Tuberculosis Disease
Self-Study Study Modules on Tuberculosis Targeted Testing and the Diagnosis of Latent Tuberculosis Infection and Tuberculosis Disease 1 Module 3: Objectives At completion of this module, learners will
More informationCategory Description / Key Findings Publication
PUBLICATIONS Selected T-SPOT.TB test publications, by area of interest, up to 31 th August 2016. Category Description / Key Findings Publication Background A useful primer on the evolution, administration
More informationTuberculin skin testing underestimates a high prevalence of latent tuberculosis infection in hemodialysis patients
Kidney International, Vol. 65 (2004), pp. 1826 1834 CLINICAL NEPHROLOGY EPIDEMIOLOGY CLINICAL TRIALS Tuberculin skin testing underestimates a high prevalence of latent tuberculosis infection in hemodialysis
More informationValidity of interferon-c-release assays for the diagnosis of latent tuberculosis in haemodialysis patients
ORIGINAL ARTICLE BACTERIOLOGY Validity of interferon-c-release assays for the diagnosis of latent tuberculosis in haemodialysis patients W. K. Chung 1,2, Z. L. Zheng 1, J. Y. Sung 1, S. Kim 1,H.H.Lee 1,
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Tuberculosis: interferon gamma tests for the diagnosis of latent tuberculosis (partial update) 1.1 Short title Tuberculosis
More informationOrganic dust-induced interleukin-12 production activates T- and natural killer cells
Eur Respir J 22; 2: 686 69 DOI:.1183/931936.2.222 Printed in UK all rights reserved Copyright #ERS Journals Ltd 22 European Respiratory Journal ISSN 93-1936 Organic dust-induced interleukin-12 production
More informationApproaches to LTBI Diagnosis
Approaches to LTBI Diagnosis Focus on LTBI October 8 th, 2018 Michelle Haas, M.D. Associate Director Denver Metro Tuberculosis Program Denver Public Health DISCLOSURES I have no disclosures or conflicts
More informationRapid antigen-specific T cell enrichment (Rapid ARTE)
Direct ex vivo characterization of human antigen-specific CD154+CD4+ T cell Rapid antigen-specific T cell enrichment (Rapid ARTE) Introduction Workflow Antigen (ag)-specific T cells play a central role
More informationImproved diagnosis of extrapulmonary tuberculosis by antigen detection using immunochemistry-based assay. Tehmina Mustafa
Improved diagnosis of extrapulmonary tuberculosis by antigen detection using immunochemistry-based assay Tehmina Mustafa Overview Introduction: extrapulmonary tuberculosis (TB) & diagnostic challenges
More informationChildren in contact with adults with
Eur Respir J 13; 41: 644 648 DOI: 1.1183/931936.12212 CopyrightßERS 13 Use of tuberculin skin test, IFN-c release assays and IFN-c-induced protein-1 to identify children with TB infection Mohammed A. Yassin*,#,
More informationBackground & objectives
Indian J Med Res 123, February 2006, pp 119-124 Influence of sex, age & nontuberculous infection at intake on the efficacy of BCG: re-analysis of 15-year data from a double-blind randomized control trial
More informationOptimizing Intracellular Flow Cytometry:
Optimizing Intracellular Flow Cytometry: Simultaneous Detection of Cytokines and Transcription Factors Presented by Jurg Rohrer, PhD, BD Biosciences 23-10780-00 Outline Introduction Cytokines Transcription
More informationCHILDHOOD TUBERCULOSIS: NEW WRINKLES IN AN OLD DISEASE [FOR THE NON-TB EXPERT]
CHILDHOOD TUBERCULOSIS: NEW WRINKLES IN AN OLD DISEASE [FOR THE NON-TB EXPERT] QUESTION: : Which children in the United States should get a tuberculin skin test? Do questionnaires really work? Jeffrey
More informationComparison of Quantiferon-TB Gold With Tuberculin Skin Test for Detecting Latent Tuberculosis Infection Prior to Liver Transplantation
American Journal of Transplantation 2007; 7: 2797 2801 Blackwell Munksgaard C 2007 The Authors Journal compilation C 2007 The American Society of Transplantation and the American Society of Transplant
More informationDiagnostic Usefulness of a T-cell-based Assay for Extrapulmonary Tuberculosis in Immunocompromised Patients
CLINICAL RESEARCH STUDY Diagnostic Usefulness of a T-cell-based Assay for Extrapulmonary Tuberculosis in Immunocompromised Patients Sung-Han Kim, MD, a,b,c Kyoung-Ho Song, MD, a Su-Jin Choi, MS, b Hong-Bin
More informationSelf-Study Modules on Tuberculosis
Self-Study Modules on Tuberculosis Targe te d Te s ting and the Diagnosis of Latent Tuberculosis Infection and Tuberculosis Disease U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control
More informationT uberculosis still remains a major health problem. Protection against tuberculosis: cytokines, T cells, and macrophages REPORT. S H E Kaufmann...
ii54 REPORT Protection against tuberculosis: cytokines, T cells, and macrophages S H E Kaufmann... Tuberculosis remains a major health problem, with two million deaths and eight million new cases annually.
More informationDifference in Cytokine Production and Cell Activation between Adenoidal Lymphocytes and Peripheral Blood Lymphocytes of Children with Otitis Media
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, Sept. 2005, p. 1130 1134 Vol. 12, No. 9 1071-412X/05/$08.00 0 doi:10.1128/cdli.12.9.1130 1134.2005 Copyright 2005, American Society for Microbiology. All
More informationClinical evaluation of QuantiFERON TB-2G test for immunocompromised patients
Eur Respir J 2007; 30: 945 950 DOI: 10.1183/09031936.00040007 CopyrightßERS Journals Ltd 2007 Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients Y. Kobashi, K. Mouri, Y. Obase,
More informationQuantiFERON-TB Gold Plus
QuantiFERON-TB Gold Plus A New Interferon-γ Release Assay (IGRA) for the Indirect Detection of Mycobacterium tuberculosis HOT TOPIC / 2018 Presenter: Elitza S. Theel, PhD, D(ABMM) Director of Infectious
More informationJCM Version 3. Utilization of the QuantiFERON-TB Gold Test in a 2-Step Process with the
JCM Accepts, published online ahead of print on 23 June 2010 J. Clin. Microbiol. doi:10.1128/jcm.02253-09 Copyright 2010, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
More informationDetailed step-by-step operating procedures for NK cell and CTL degranulation assays
Supplemental methods Detailed step-by-step operating procedures for NK cell and CTL degranulation assays Materials PBMC isolated from patients, relatives and healthy donors as control K562 cells (ATCC,
More informationMaking the Diagnosis of Tuberculosis
Making the Diagnosis of Tuberculosis Alfred Lardizabal, MD NJMS Global Tuberculosis Institute Testing for TB Infection Targeted Testing: Key Points Test only if plan for ensuring treatment De-emphasizes
More informationPatterns of cytokine response in bcg vaccinated and BCG non-vaccinated children in the age group of 5-8 years in Chennai
Available online at www.scholarsresearchlibrary.com Central European Journal of Experimental Biology, 2012, 1 (4):134-141 (http://scholarsresearchlibrary.com/archive.html) ISSN: 2278 7364 Patterns of cytokine
More informationClarithromycin-resistant Mycobacterium Shinjukuense Lung Disease: Case Report and Literature Review
Showa Univ J Med Sci 28 4, 373 377, December 2016 Case Report Clarithromycin-resistant Mycobacterium Shinjukuense Lung Disease: Case Report and Literature Review Makoto HAYASHI 1, Satoshi MATSUKURA 1,
More informationNew NICE guideline updates recommendations for diagnosing latent tuberculosis
Tel: 0845 003 7782 www.nice.org.uk Ref: 2011/053 PRESS RELEASE New NICE guideline updates recommendations for diagnosing latent tuberculosis The National Institute for Health and Clinical Excellence (NICE)
More informationTNF-alpha antagonist therapy modify the tuberculin skin test response
DOI 10.1007/s00296-010-1424-3 ORIGINAL ARTICLE TNF-alpha antagonist therapy modify the tuberculin skin test response Tulin Cagatay Zeki Kilicaslan Penbe Cagatay Munevver Mertsoylu Ziya Gulbaran Reyhan
More informationTuberculosis Update. Topics to be Addressed
Tuberculosis Update Robert M. Jasmer, M.D. University of California, San Francisco TB Control Section, San Francisco Department of Public Health Topics to be Addressed TB in the USA Screening recommendations
More informationDiagnostic challenges of active childhood TB in Tanzania. Michala Vaaben Rose, MD, Ph.D Department of Infectious Diseases, Hvidovre
Diagnostic challenges of active childhood TB in Tanzania Michala Vaaben Rose, MD, Ph.D Department of Infectious Diseases, Hvidovre 1 Diagnosis of Childhood Tuberculosis Muheza hospital, TZ Hilleroedhospital.dk
More informationSupplemental Information. T Cells Enhance Autoimmunity by Restraining Regulatory T Cell Responses via an Interleukin-23-Dependent Mechanism
Immunity, Volume 33 Supplemental Information T Cells Enhance Autoimmunity by Restraining Regulatory T Cell Responses via an Interleukin-23-Dependent Mechanism Franziska Petermann, Veit Rothhammer, Malte
More informationIdentification of Mycobacterium tuberculosis-specific genomic regions encoding antigens inducing protective cellular immune responses
Indian Journal of Experimental Biology Vol. 47, June 2009, pp. 498-504 Identification of Mycobacterium tuberculosis-specific genomic regions encoding antigens inducing protective cellular immune responses
More informationEx vivo Human Antigen-specific T Cell Proliferation and Degranulation Willemijn Hobo 1, Wieger Norde 1 and Harry Dolstra 2*
Ex vivo Human Antigen-specific T Cell Proliferation and Degranulation Willemijn Hobo 1, Wieger Norde 1 and Harry Dolstra 2* 1 Department of Laboratory Medicine - Laboratory of Hematology, Radboud University
More informationAPPLICATION OF IMMUNO CHROMATOGRAPHIC METHODS IN PLEURAL TUBERCULOSIS
APPLICATION OF IMMUNO CHROMATOGRAPHIC METHODS IN PLEURAL TUBERCULOSIS Hadizadeh Tasbiti.AR, Yari.SH, Bahrmand.AR, Karimi.A,Fateh.A, Sayfi.M Tuberculosis Dept.Pasteur Institute of Iran.Tehran.Iran 1 INTRODUCTION
More information